Aptose Biosciences Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Product Pipeline
    • Overview
    • Tuspetinib for AML
    • Luxeptinib for B-cell Tumors
    • Luxeptinib for Myeloid Tumors
    • Posters & Presentations
  • Clinical Trials
    • Overview
    • Luxeptinib for CLL & NHL
    • Luxeptinib for AML
    • Tuspetinib for AML
    • Expanded Access
  • News
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • SEDAR
    • Governance
  • Join Us
    • Values & Culture
    • Perks & Benefits
    • Explore Careers
  • Contact

Press Releases

News

News

  • Press Releases
  • Presentations
  • Events

Aptose to Present New CG’806 Data at the 23rd Congress of the European Hematology Association

May 17, 2018 11:43am EDT

Aptose Reports Results for the First Quarter Ended March 31, 2018

May 10, 2018 4:00pm EDT

Aptose Exercises Early Option for CG-806 License From CrystalGenomics

May 07, 2018 7:00am EDT

Aptose To Release First Quarter Ended March 31, 2018 Financial Results and Hold Conference Call on May 10, 2018

May 01, 2018 7:30am EDT

Aptose Announces Appointment of Caroline M. Loewy to Board of Directors

Apr 25, 2018 7:00am EDT

Aptose to Present at the Bloom Burton & Co. Healthcare Investor Conference 2018

Apr 24, 2018 7:00am EDT

Aptose Presents Preclinical Data on APTO-253 at 2018 AACR Annual Meeting

Apr 17, 2018 2:00pm EDT

OHSU and Aptose Present New CG’806 Preclinical Data at 2018 AACR Annual Meeting

Apr 16, 2018 7:30am EDT

Aptose Presents New Preclinical Data on CG’806 Pan-FLT3/ Pan-BTK Inhibitor at 2018 AACR Annual Meeting

Apr 16, 2018 7:30am EDT

Aptose to Present at the H.C. Wainwright Annual Global Life Sciences Conference

Apr 03, 2018 8:00am EDT
RSS
  • Prev
    • 1...
    • 18
    • 19
    • 20
    • 21
    • 22
    • 23
    • 24
    • 25
    • 26
    • 27
    • ...33
    Next
    © 2025 Aptose Biosciences Inc. All Rights Reserved.
    Privacy Policy Clinical Trials Policy Disclaimer Sitemap Manage Cookie Preferences